Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 24;7(1):64-66.
doi: 10.1016/j.jacbts.2021.11.008. eCollection 2022 Jan.

Cardioprotection Achieved Through Overexpression of Relaxin Receptors

Affiliations
Editorial

Cardioprotection Achieved Through Overexpression of Relaxin Receptors

Xiao-Jun Du. JACC Basic Transl Sci. .
No abstract available

Keywords: gene therapy; ischemia-reperfusion; relaxin; relaxin family peptide receptor; serelaxin.

PubMed Disclaimer

Conflict of interest statement

The author has reported that he has no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract

Comment on

  • doi: 10.1016/j.jacbts.2021.10.012

Similar articles

References

    1. Bathgate R.A., Halls M.L., van der Westhuizen E.T., Callander G.E., Kocan M., Summers R.J. Relaxin family peptides and their receptors. Physiol Rev. 2013;93:405–480. - PubMed
    1. Sarwar M., Du X.J., Dschietzig T.B., Summers R.J. The actions of relaxin on human cardiovascular system. Br J Pharmacol. 2017;147:933–949. - PMC - PubMed
    1. Devarakonda T., Mauro A.G., Cain C., Das A., Salloum F.N. Cardiac gene therapy with relaxin receptor 1 overexpression protects against acute myocardial infarction. J Am Coll Cardiol Basic Trans Science. 2022;7(1):53–63. - PMC - PubMed
    1. Ponikowski P., Mitrovic V., Ruda M., et al. A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure. Eur Heart J. 2014;35:431–441. - PMC - PubMed
    1. Halls M.L. Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation. Br J Pharmacol. 2012;165:1644–1658. - PMC - PubMed

Publication types

LinkOut - more resources